A live archive of receipt-bound excerpts from company earnings calls. No generated thesis, no recommendation — just the recorded language, its source coordinates, and a direct path into the ticker dossier or live Terminal.来自公司财报电话会的可追溯摘录档案。没有生成式投资结论，也没有推荐——只有原始表述、来源坐标，以及进入个股档案或实时终端的直接入口。
Start free in Terminal免费开始使用终端649 verified call records份已核验电话会记录 · 7788 exact facts条精确事实 · 2026-10-26 → 2026-11-01
Browse the full archive page by page. Search on this page by ticker, period, category, or speaker; every card preview is a verbatim call excerpt.分页浏览完整档案。在本页按代码、期间、分类或发言人搜索；每张卡片预览均为电话会原文摘录。
Showing records 4897–4992 of 6702.显示第 4897–4992 条，共 6702 条。
“Net loss attributable to DNOW for the first quarter was a loss of $44 million or a loss of $0.24 per diluted share and was unfavorably impacted by $41 million in inventory step-up to the fair market value amortization charges related to the merger, reduced margins and increased SG&A expenses.”
“After formally releasing our 3-year interim financial target earlier this year, which includes reaching $2 billion in annual revenue, $700 million in gross profit, and over $4 in non-GAAP EPS, this quarter was a great first step toward executing on these goals.”
“To put the scale of this opportunity in perspective and using SPRAVATO's average annual price as a surrogate, capturing just 1% of the total addressable market in these indications represents potential for a roughly $2 billion annual revenue opportunity.”
“The result, 25 years in, is a company that has returned approximately $1.2 billion to shareholders in dividends and share repurchases since IPO, that has grown EBITDA per share at a 12% compounded annual growth rate over the last five years, and that will control over 1,000 Oklahoma undeveloped drilling locations, over 38,000 mi of midstream pipeline, operations in four distinct basins, including high-quality Permian assets, and a daily production platform of over 1.2 BCF per day.”
“Revenue growth accelerated with our broad base of customers, excluding the AI natives, to mid-20s percent year-over-year, up from 23% last quarter and 19% in the year-ago quarter.”
“Our guidance takes into account expected seasonal trends in the third and fourth quarters, much like in 2025 when new patient starts rates declined partially due to scheduling challenges.”
“We delivered a strong start to the year, exceeding the high end of our guidance across revenue and operating margin with year-over-year revenue growth of 2%, excluding FormSwift, and unlevered free cash flow margin of 38%.”
“The acquisition of Clinical Solutions, which we expect to generate $215 million-$230 million of revenue in 2026 and contribute $0.03-$0.05 per share, net of interest incurred to finance the acquisition, partially offset by a reduction of $0.09-$0.15 per share for lower ICE populations compared with our previous forecast.”
“Adjusted EBITDA margin increased approximately 80 basis points to 19%, driven by the SAT volume flow-through and the realization of operating synergies in authentication.”
“Our trailing 12 months free cash flow was approximately 70% of adjusted net income, in line with our target range of a 60%-80% free cash flow conversion rate.”
“Moving to the full year outlook, we are reaffirming our full year 2026 CAFD guidance range of $470 million-$510 million as we continue to believe we are well positioned to meet our 2026 financial objectives based on growth commitments tracking on schedule and expected operational performance for the remainder of the year.”
“Moving to the full year outlook, we are reaffirming our full year 2026 CAFD guidance range of $470 million-$510 million as we continue to believe we are well positioned to meet our 2026 financial objectives based on growth commitments tracking on schedule and expected operational performance for the remainder of the year.”
“Regarding the segment's profitability, we now expect operating income growth of 13%-15% and operating margin expansion of 40 to 60 basis points, with this uplift mainly driven by the stronger revenue outlook.”
“Excluding the timing impact, consolidated adjusted EBITDA would have increased 14.2% to $145.9 million, and consolidated adjusted EBITDA margin would have been 28.9%, up 150 basis points from the prior year.”
“The next comprehensive update that we plan to provide will not only include, of course, data across the 130-13 patient phase I study, but will also include guidance as to where we're going next in terms of design of the first pivotal study, what the patient population is, what the comparator arm is, and of course, what the dose is.”
“Service revenue alone grew 15% year-over-year to $15.4 million, continuing to benefit from growth in our installed base and the active utilization of our instruments by customers worldwide.”
“We believe continued transparency into bookings and ACV to revenue conversion metrics will serve as an important leading indicator towards our 2028 top line revenue target exceeding $1.1 billion and broader Vision 2030 financial glide path.”
“Adjusted free cash flow was $2.2 million lower than the prior year first quarter, as the first quarter of 2025 was impacted by special payments for professional services related to the review of strategic alternatives, as well as severance payments.”
“The strength of our Q1 results, disciplined execution, and continued momentum we are seeing across our customer base gives us confidence in reaffirming our full-year guidance of $12 billion-$13 billion of revenue and $900 million-$1.1 billion of adjusted operating income.”
“Our gamer and creator peripherals segment gross profit grew 8% to $50.3 million despite year-over-year tariff related headwinds, with segment gross margin of 14.8%.”
“We expect our non-GAAP operating expenses, which exclude cost of product revenue, stock-based compensation, depreciation, and amortization, to be between $480 million and $520 million.”
“The strong bookings performance at the end of 2025 and a continuation of favorable trends to start this year leave us cautiously optimistic that the net book-to-bill will average about 1x for the year and support the upper end of our DSA outlook, including a return to organic revenue growth in the second half.”
“Offsetting these improvements were $7 million of unfavorable volume and mix, including customer price adjustments and the impact of certain short-term production disruptions, $7 million in increased costs in the form of higher wages and general inflation, $2 million from unfavorable foreign exchange, and $12 million of other unfavorable items, primarily the non-recurrence of certain royalty payments we received in the first quarter of last year.”
“We're raising full year 2026 revenue guidance today to $5.29 billion at the midpoint.”
“The total revenue, net revenue guidance of $805 million-$825 million contemplates the impact of the various generic dynamics.”
“While we don't know the exact timing of when the transaction will close, we estimate that the JV could be a full year headwind to AFFO of approximately $0.10 per share, or roughly $0.06 per share for the second half of 2026.”
“Turning to our outlook, we expect subscription and services revenue in the range of $565 million-$645 million with an opportunity for quarter-over-quarter growth.”
“While there was a limited impact of higher diesel prices in Q1, we expect it to weigh on our PRB margins in the future periods if these elevated prices continue.”
“With our high-quality production mix, strong cost structure, and substantial free cash flow at current strip pricing, our next targeted debt level of CAD 13 billion is approaching, at which time we increase shareholder returns to 100% of free cash flow.”
“While rewarding our shareholders as a result of increased cash flows, profitability, and visibility, the payment of that dividend is not expected to affect our capacity to continue growing on a healthy basis in a volatile market environment.”
“In the Plant Nutrition segment, revenue was $67 million compared to $58 million in the prior year Q2.”
“Given our strong operating results, great acquisition, and continued share repurchases, as well as improved outlook for the remainder of the year, we have increased our guidance by approximately 15% since February.”
“Our risk-graded three investments, which are investments where we expect full repayment, but are either spending more engagement time and/or have seen increased risks, the initial asset purchase increased from approximately 11.5% in Q4 to 12.9% in Q1.”
“Despite volatility, origination volume increased 39% compared to the first quarter of 2025, reaching $884 million.”
“For international business group, both of his revenue and income before tax grew positively by 10.7% and 1.6% respectively, driven by the rising ICT service demand from the overseas AI supply chain, together with stronger roaming performance.”
“adjusted EBITDA margin reached 26.9%, expanding 1,010 basis points year-over-year and exceeding the midpoint of guidance by more than 600 basis points, driven by strong revenue growth and favorable mix.”
“buyout realizations, a high level of inflows, fee-related earnings of $300 million and a 47% margin.”
“We continue to efficiently convert EBITDA to free cash flow at industry-leading margins, positioning the company well to continue to invest in accretive growth and return capital to shareholders.”
“specifically, we are already beginning to see increased value-added product demand following President Trump's April 2nd, 2026 executive order that closed valuation loopholes that importers have been using to cheat the Section 232 system, especially in downstream extruded products.”
“When you're looking at Q1 to Q2, we're anticipating for modeling purposes, a sidestep in overall margin with additional opportunities for further enhancements leading into Q3 and Q4 as we progress closer to that low 50% gross profit target.”
“For the first quarter of 2026, the increase was primarily driven by product mix and sales declines in several low margin products that were replaced with more profitable product sales.”
“With our 2026 guidance reaffirmed and using our 2026 budget prices, we expect to generate more than $3 billion of EBITDA and $2 billion of free cash flow, as shown on slide seven, even with only nine months and 11 days of contributions from New Afton and Rainy River.”
“Gross profit increased 10.2%, and gross margin rose 278 basis points compared to last year, mainly driven by lower costs coming from the 8.1% appreciation of the Chilean peso against the U.S.”
“Our Q1 financial results were driven by an 8.2% revenue growth in our corporate channel, driven by record usage as well as a continuation of customer acquisition across our continuum.”
“We are also reaffirming full year 2026 guidance of flat to 2% revenue growth and adjusted EBITDA margin of 29%-30%.”
“First quarter revenue grew 15% year-over-year to $244 million, above the midpoint of our guidance range, driven by strength from our strong year-end 2025 bookings, as well as continued momentum in our international business, with slight moderation in OEM advertising reflecting the typical first quarter step down.”
“In golf ball, our revenues were up 2% in Q1, but I believe this underrepresents the strength of our start to the year in this category, as our Q1 volumes were intentionally reduced by the elimination of low-margin SKUs, as well as by lower sell-in volumes at retail in support of improved inventory efficiency.”
“This strong revenue performance, combined with the operating leverage inherent in our business model, has produced continued positive financial results while we ramp up investments, including revenue growth of 79%, which was driven by volume growth of 15% and a 61% increase in clinical ASP.”
“We expect repayment volumes to continue, with that, we can manage to the high end of our range of 1-1.25 turns.”
“If end of April exchange rates would prevail throughout the remainder of the year, our Q2-Q4 GAAP revenues would be negatively impacted by approximately $3 million, relative to the exchange rates assumed in our 2026 financial outlook.”
“At the midpoint, our outlook implies an adjusted EBITDA margin of around 10%, driven by our expectations for a relatively flat gross margin performance year-over-year and slight operating expense deleverage to invest in our 2026 and 2027 greenfield store growth, including continued expansion into the Southeast and the associated marketing expense.”
“We view the yield impact as transitory and a key operational priority throughout 2026, and as it is resolved, we expect a corresponding expansion in gross margin.”
“We expect to fully market our own volumes by mid-2026.”
“With the momentum we are seeing for Gen-3 services, we are increasing our revenue guidance for the year from our previous range of $120 million-$145 million to an updated range of $130 million-$150 million, representing an overall growth rate of over 30% at the midpoint as compared to 2025.”
“Given stronger forecasted cash flows in 2026, driven by new capital projects placed in service, executing upon our regulatory initiatives, and increasing large load customer growth, compared to last year, we expect a significantly lower total equity need of $50 million-$70 million in 2026.”
“For all these reasons, we remain confident in our 2026 annual guidance of 8%-9% RevPAR growth and Adjusted EBITDA range of $502 million-$516 million, as well as with our multi-year growth outlook of mid-teens annual growth of Adjusted EBITDA.”
“For fiscal Q4 2026, we expect total revenue to be in the range of $425 million-$435 million and core revenue to be in the range of $392 million-$402 million, reflecting 13%-16% year-over-year growth.”
“We expect to generate revenues of between $785 million and $845 million compared to $784 million in the second quarter of 2025, which at the midpoint of our guidance, would represent a 4% revenue growth increase for the second quarter and 22% revenue growth for the first half of the year, or 13% organically.”
“We expect funded loan volume of approximately $1.65 billion, representing approximately 37% year-over-year growth, slower than what we had originally anticipated going into Q2.”
“We delivered solid second quarter with $4.7 billion in revenue, up 2.6%, reflecting broad-based growth across most of the portfolio, with a stronger contribution from higher margin businesses and disciplined execution through a dynamic environment.”
“We increased our AI-powered solutions revenue objective from approximately CAD 1.5 billion to approximately CAD 2 billion by 2028 when we made the Saskatchewan announcement, we're confident in that target.”
“Looking ahead, we expect the trend in loss from operations to flatten over the next 2 quarters as we ramp up launch readiness activities for the next 3 products and continue narrowing towards the end of this year to 2027 as we transition to a P&L breakeven, followed by cash flow positivity, which we expect to be sustainable from that point on.”
“Supply costs increased by $5.1 million, mostly driven by higher overall per unit purchase water costs included in water rates in 2026, with no impact to net earnings, and higher purchase water volume when compared to the same quarter last year.”
“Lastly, we now expect full year non-GAAP operating income of $91.5 million to $94.5 million, which includes the Q1 beat of $700,000, offset by an FX headwind of $2.2 million.”
“In the second quarter, we expect a return to low single-digit growth, primarily driven by favorable comparisons following the demand slowdown that began in the second quarter of 2025.”
“There is a very strong correlation between size and price per NAV in the gold sector as we come from, in the past 200,000 ounces of production, now on guidance 340 and 390.”
“The largest filing we expect to implement during the second half of the fiscal year, APT's GRIP filing seeking $112 million in annualized operating income increases, is scheduled to be considered by the Railroad Commission of Texas next Tuesday, 12 May.”
“Net margin increased over 60% year-over-year to $190 million, reflecting the earnings contribution from a larger receivable base, partially offset by higher funding costs and the higher fair value impacts associated with portfolio growth.”
“Based on bookings and quoting activity, we expect the percentage of revenue from AI applications in our Thermal Processing Solutions segment to exceed 40% in the third quarter.”
“For as an example, from 2019 through guidance for 2026, we've grown revenue at approximately a 32% CAGR and adjusted EBITDA at 25% CAGR, while continuing to generate, you know, operating leverage and free cash flow along the way as we grow very, very rapidly.”
“Gross profit of $4.3 million or 11% gross margin reflected the impact of lower production volumes being unable to fully cover fixed manufacturing costs.”
“As revenue scales, we expect meaningful improvement in our operating margin, which will be visible over the course of 2026 and beyond.”
“Excluding flight equipment sales, which tend to be volatile quarter-to-quarter, revenue increased 2.2% year-over-year, reflecting growth in leasing and increased demand across our MRO facilities.”
“In addition to last week's activity update and TCE guidance, we report today adjusted earnings of $23.6 million or $0.58 per share.”
“On slide 6, sales for the first quarter increased $2.7 billion year-over-year to $9.5 billion, exceeding our guidance range and up 39% versus the prior year or up 34% versus the prior year on a constant currency basis.”
“Additionally, we remain confident that we will achieve the full year 2026 financial outlook, which we provided last quarter on subscriptions and services revenue as well as total revenue and EPS.”
“Merchandising margin was 33.9%, up 70 basis points from the prior year, driven by product mix and targeted customer promotions.”
“At Segovia, our AISC margin increased at $2,935 per ounce, up 128% from Q1 2025 and up 25% from Q4 2025, reflecting higher realized gold prices and increased gold sales volumes.”
“For the second quarter of 2026, we expect net revenue between $350 million-$370 million for a year-over-year growth rate of down 2.4% to up 3.2%, with comparable delivered sales of -5% to flat and net income of $19 million-$24 million and adjusted EBITDA of $40 million to $49 million.”
“The 1% quarter-over-quarter growth reflects the impact of [audio distortion] injector in 2027, continued development of efgartigimod across several indications, and advancing our pipeline assets.”
“Year-over-year quarterly revenue decreased by $27.3 million.”
“Driven by AI demand, our 2026 pipeline is above our expectations and a key factor in our increased guidance for the remainder of the year.”
“Currently, as outlined on slide nine of our supplement, we expect to generate approximately $2.2 billion of free cash flow for the full year.”
“The strong results give us the confidence to increase our revenue guidance for the full year to at least $130 million, $5 million above our previous forecast.”
“epinephrine sales increased 3% to $19.2 million from $18.6 million as increased demand for our prefilled syringe product was partially offset by increased competition for our multidose vial products.”
“Nurse and allied gross margin in the quarter was 25.1%, up 240 basis points year-over-year and 350 basis points sequentially as labor disruption and rapid response revenue had a favorable impact on the segment margin.”
“As we look ahead to 2027, we expect to deliver strong year-on-year growth driven by continued expansion of our commercialized product portfolio, contributions from our pipeline, and associated milestone revenues.”
“For the second quarter of 2026, we expect SaaS and license revenue of between $185.5 million and $185.7 million.”
“Day sales outstanding were roughly 61 days in the quarter, compared with about 57 days for the full year 2025, we expect some normalization as we move through the year.”
“Our Power-Thru architecture delivers up to 40% greater efficiency, and we expect to see a 2x-3x dollar content uplift from isolated gate drivers as customers move toward 800 volt xEV platforms and higher power AI architectures.”
“We estimate that the unmitigated full year cost impact of the supply chain disruptions would be approximately $70 million-$90 million and expect it to be offset by the following: reduced interest expense following our debt reduction actions in Q1, and stronger than expected pricing and volumes in the specialties business, which gives us the confidence to increase our full year specialties outlook, which I will cover on slide eight.”
“Of these amounts, Vafseo net product revenues were $15.8 million in Q1 2026 compared to $12 million in Q1 2025, representing a 32% increase, with an even larger increase in underlying demand as evidenced by the strong Q1 patient growth Nick described, as well as by the fact that Q1 2025 revenues reflected initial customer inventory build.”
“Third, we anticipate revenue from the $1.8 billion customer win to start to ramp in Q4, and we expect to generate approximately $20 million-$25 million of revenue in the fourth quarter.”
“I think we would expect to do more of the same in fiscal 2027, but I'll stop short of giving any sort of outlook or guidance for 2027 today.”
“We started the year with a solid Q1 report, with revenue up 34% and gross margin above the middle point of our long-term targets range.”
“As Russell mentioned, this result includes a one-time impact associated with the customer settlement in the quarter, which resulted in a headwind to system revenue of $5 million, gross margins of approximately 70 basis points, and EPS of $0.09 per share.”
Try a ticker, period, category, or a call speaker.请尝试代码、期间、分类或电话会发言人。
This is a transcript-only, historically incomplete publication. Releases, filings, slides, consensus and price reaction are visibly marked as not joined; lower-evidence packets remain held instead of being inferred.这是仅基于电话会文本且历史覆盖尚不完整的发布。新闻稿、披露文件、演示材料、一致预期和股价反应均明确标注为未接入；证据不足的数据包会被暂缓，而非由推断补齐。